.
BioEnterprise

ViewRay

ViewRay, Inc. (OTCQB: VRAY) is a publically held company that develops advanced radiation therapy technology for the treatment of cancer. The MRIdian® system provides continuous soft-tissue imaging during treatment, using MRI-guided radiation therapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient’s anatomy.

Funding

OrbiMed Advisors, Fidelity Biosciences, Kearny Venture Partners, Aisling Capital, Siemens Venture Capital, Cowealth Medical Holding Company, JumpStart, Montrose Capital, Xeraya Capital

Stage

Commercial